2006
DOI: 10.1016/j.bbrc.2006.07.130
|View full text |Cite
|
Sign up to set email alerts
|

Protein misfolding cyclic amplification as a rapid test for assessment of prion inactivation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
24
0

Year Published

2007
2007
2024
2024

Publication Types

Select...
5
4

Relationship

2
7

Authors

Journals

citations
Cited by 33 publications
(24 citation statements)
references
References 14 publications
0
24
0
Order By: Relevance
“…The PMCA assay has a wide dynamic range of sensitivity (31). This assay considerably reduces the time required for generating results (i.e., 3 days) compared to animal bioassay models (several months to more than a year), and studies examining heat sterilization of PrP Sc demonstrated that results obtained by PMCA correlated with animal infectivity (22,36).…”
mentioning
confidence: 99%
“…The PMCA assay has a wide dynamic range of sensitivity (31). This assay considerably reduces the time required for generating results (i.e., 3 days) compared to animal bioassay models (several months to more than a year), and studies examining heat sterilization of PrP Sc demonstrated that results obtained by PMCA correlated with animal infectivity (22,36).…”
mentioning
confidence: 99%
“…Although most of the work by Soto's group concerns a hamster model infected by strain 263K, significant amplification has been achieved with the PrP Sc produced by various mammalian species, including mice [47,72], sheep, goats and cattle [72], cervids [38] and humans [36]. The PrP Sc newly formed by PMCA has all the properties of the original PrP Sc , notably its infectious character [14,82].…”
Section: Protein Misfolding Cyclic Amplificationmentioning
confidence: 99%
“…The brains of hamsters at the terminal stage of the disease, titrating 5 Â 10 8:5 LD 50 per gram by bioassay, 16) were pooled together and homogenized at a concentration of 20% (w/v) in phosphatebuffered saline (PBS). The homogenate was mixed with an equal volume of 0.2% (w/v) FeCl 2 -PBS solution in the presence of 5% (v/v) H 2 O 2 .…”
Section: Prpmentioning
confidence: 99%
“…The PMCA procedure followed was based on that reported in our previous study. 16) Briefly, the treated sample was diluted 1:10 in 10% uninfected brain homogenate, and one round of the PMCA reaction was performed by applying 40 cycles of sonication, followed by incubation at 37 C for 1 h. Next, the process diluting the PMCA product to 1:10 and its subsequent amplification was repeated two times. With regard to the PMCA products, samples (10 ml) collected before and after each round of amplification were mixed with 10 ml PK solution (100 mg/ml) and incubated at 37…”
Section: Prpmentioning
confidence: 99%